Total Medicaid payments for services directly linked to COVID-19 in Easley reached at least $11,526 for 2024, data from the U.S. Department of Health and Human Services Medicaid Provider Spending database shows.
Medicaid, a public health insurance initiative, is managed by states and financed through a partnership between federal and state governments. The program supports low-income residents, seniors, children, and individuals with disabilities and is among the largest segments of the nation’s health care landscape.
Shifts in Medicaid payment levels reflect how taxpayer-funded health dollars are distributed within a local area.
Analysts identified COVID-19–related services for this review by selecting claims billed under HCPCS codes explicitly marked as “COVID-19” or “coronavirus” in their billing descriptions or related datasets. As a result, the totals capture only services labeled as COVID-19–related within billing records, omitting any pandemic care billed under more general medical codes.
As a reference, Columbia reported the highest Medicaid payout for COVID-19 services in South Carolina for 2024, amounting to $1,102,671 in claims related to the virus.
During 2024, three providers in Easley submitted Medicaid claims under COVID-19–related categories. Immunoassay services represented the largest share of these claims, totaling $11,455.
The average Medicaid payment per provider for COVID-19–specific services in Easley, at $3,842, was lower than the statewide average of $37,377.
Medicaid payment totals for all other claim types increased by $6,779,578 from 2020 to 2024, corresponding to 105.1% growth.
Centres for Medicare & Medicaid Services data indicates combined state and federal Medicaid spending rose to roughly $871.7 billion in fiscal 2023, or about 18% of total U.S. health care expenditures, a significant jump from the approximately $613.5 billion spent in 2019, prior to the onset of COVID-19.
This jump marks an increase of about 40% over several years, attributed mainly to higher enrollment numbers and increased utilization during and after the pandemic period.
Recent national fiscal legislation enacted during the Trump administration included major measures to decrease federal Medicaid spending and make structural changes. The “One Big Beautiful Bill Act,” enacted in 2025, is expected to reduce federal Medicaid expenditures by over $1 trillion over 10 years. It also brings in work requirements and increased cost-sharing provisions that could cut coverage and financial support for certain groups. These policy shifts are likely to result in increased costs for states and restrain the pace of federal Medicaid growth, even while the program continues to assist millions across the U.S.
| Year | COVID-19–Related Payments | COVID-19 Payments % Change (YoY) | Total Medicaid Payments |
|---|---|---|---|
| 2024 | $11,526 | -85.7% | $13,239,217 |
| 2023 | $80,447 | -81.8% | $14,494,464 |
| 2022 | $442,128 | -36.3% | $14,482,461 |
| 2021 | $694,076 | 193.6% | $8,717,239 |
| 2020 | $236,394 | N/A | $6,684,507 |
| 2019 | $0 | N/A | $9,311,465 |
| 2018 | $0 | N/A | $10,801,684 |
| HCPCS Code | Description | Medicaid Payments | Claims |
|---|---|---|---|
| 87811 | Immunoassay | $11,455 | 405 |
| M0201 | COVID-19 Vaccine Administration | $71 | 20 |
Note: HCPCS codes include only those specifically labeled for COVID-19 services; figures do not encompass all spending linked to pandemic care.
This article is based on information from the U.S. Department of Health and Human Services Medicaid Provider Spending database. Access the source data here.

